MilliporeSigma News
-
MilliporeSigma Announces Support Of SaudiVax In Becoming First Developer And Manufacturer Of Halal Vaccines And Biotherapeutics In Saudi Arabia
3/18/2022
MilliporeSigma, the U.S. and Canadian Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, announced that the Life Science business sector will support SaudiVax Ltd., based in the Kingdom of Saudi Arabia, to design a best-in-class, multi-modality manufacturing facility to localize manufacturing of biologics and vaccines for the MENA region.
-
MilliporeSigma To Manufacture Next-Generation Biotherapeutics For Alteogen
3/18/2022
MilliporeSigma announced an agreement with Alteogen, Inc., of South Korea, providing late-stage CDMO services through MilliporeSigma’s BioReliance® End-to-End Solutions. Alteogen selected MilliporeSigma to develop and produce recombinant biologics for the development and clinical evaluation of next-generation therapeutics of monoclonal antibody drugs.
-
MilliporeSigma Announces Organizational Transformation To Strengthen CDMO Offering And Accelerate Future Growth
3/18/2022
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced several organizational changes and a new operating model to support the long-term growth strategy of the Life Science business sector and to better serve the evolving needs of its global customers.
-
MilliporeSigma’s Bio4C Orchestrator™ Software Optimizes Processes, Improves Compliance And Time To Market
11/18/2020
MilliporeSigma today launched itsBio4C Orchestrator™ Software, which allows users to monitor multiple unit operations remotely from a centralized dashboard.
-
MilliporeSigma Advances Bioprocessing Capabilities With Raman Technology Sensor Acquisition
7/1/2020
Merck, a leading science and technology company, today enhanced its advanced bioprocess portfolio through the acquisition of RESOLUTION Spectra Systems, a Meylan, France-based leader in bioprocess analytical monitoring.
-
MilliporeSigma Accelerates Readiness Of Bioprocessing Facility Of The Future
4/30/2020
MilliporeSigma today unveiled the next component of its BioContinuum™ Platform, the Bio4C™ Software Suite, creating a first-of-its-kind ecosystem that combines process control, analytics and plant-level automation. This transformative software suite will allow users to look across the entire manufacturing process versus individual operational units, giving biomanufacturers complete process control and deep insights, bringing Bioprocessing 4.0 to the here and now.